You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Motor Fluctuations

Showing 1 - 25 of 6,977
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Parkinson Disease Trial in Port Orange, Decatur (Lenrispodun, Placebo)

Recruiting
  • Parkinson Disease
  • Port Orange, Florida
  • +1 more
Mar 10, 2023

Parkinson Disease Trial in Lille (A-dopamine, optimized oral treatment)

Recruiting
  • Parkinson Disease
  • Lille, France
    Hopital Roger Salengro, CHU Lille
Oct 11, 2022

Parkinson's Disease Trial in Tampa (levetiracetam, Placebo)

Withdrawn
  • Parkinson's Disease
  • Tampa, Florida
    University of South Florida
Nov 8, 2021

Parkinson Disease Trial in United States (CVN424 Low Dose, CVN424 High Dose, Placebo)

Completed
  • Parkinson Disease
  • CVN424 Low Dose
  • +2 more
  • Long Beach, California
  • +20 more
Aug 4, 2022

Parkinson's KinetiGraph as Tool for DBS Eligibility Assessment

Completed
  • Parkinson's Disease
  • Parkinson's Kinetigraph
  • La Tronche, France
  • +1 more
Jan 11, 2022

Parkinson Disease Trial in London (Opicapone 50 mg, Matching )

Recruiting
  • Parkinson Disease
  • Opicapone 50 mg
  • Matching placebo
  • London, United Kingdom
    The Maurice Wohl Clinical Neuroscience Institute - King's Colleg
Jul 27, 2021

Parkinson Disease Trial in Rome (Standard LD/CD, Semi continuous intra-oral administration of LD/CD)

Completed
  • Parkinson Disease
  • Standard LD/CD
  • Semi continuous intra-oral administration of LD/CD
  • Rome, Italy
    Irccs San Raffaele Pisana
Oct 17, 2022

Parkinson's Disease Trial in United States (VY-AADC02, Sham (Placebo) Surgery)

Active, not recruiting
  • Parkinson's Disease
  • VY-AADC02
  • Sham (Placebo) Surgery
  • Irvine, California
  • +19 more
Mar 17, 2022

Parkinson Disease Trial (Opicapone, L-DOPA/DDCI)

Not yet recruiting
  • Parkinson Disease
  • (no location specified)
Oct 13, 2021

Parkinson Disease Trial in Guimarães (Opicapone)

Recruiting
  • Parkinson Disease
  • Guimarães, Portugal
    Hospital da Senhora da Oliveira - Guimarães, E.P.E, Serviço de N
Aug 2, 2021

Parkinson's Disease Trial in Peoria, Bingham Farms (Sinemet 25-100 Oral Tablet, XP21279, Carbidopa Pill)

Completed
  • Parkinson's Disease
  • Sinemet 25-100 Oral Tablet
  • +2 more
  • Peoria, Arizona
  • +1 more
Apr 30, 2021

Parkinson Disease Trial in Worldwide (Tavapadon, Placebo)

Recruiting
  • Parkinson Disease
  • Phoenix, Arizona
  • +145 more
Dec 20, 2022

Two Non-motor Scales in PD (NFS and SPARK)

Recruiting
  • Parkinson's Disease
  • Non-motor Symptoms
    • Besançon, France
    • +7 more
    Aug 2, 2021

    Parkinson Disease Trial in Spain (device, diagnostic test, other)

    Recruiting
    • Parkinson Disease
    • Parkinson Holter
    • +2 more
    • Hospitalet de Llobregat, Barcelona, Spain
    • +42 more
    Mar 9, 2022

    Local Fields Potentientals of Subthalamic Nucleus in Parkinson's

    Recruiting
    • Parkinson Disease
    • LFP and EEG recording
    • Grenoble, France
      CHU Grenoble Alpes
    Apr 20, 2023

    Parkinson Disease Trial in Worldwide (ExAblate Pallidotomy, Sham ExAblate Pallidotomy)

    Active, not recruiting
    • Parkinson Disease
    • ExAblate Pallidotomy
    • Sham ExAblate Pallidotomy
    • Stanford, California
    • +19 more
    Nov 5, 2020

    Parkinson Disease, Motor Disorder Trial in United States (BTRX-246040, Placebo)

    Completed
    • Parkinson Disease
    • Motor Disorder
    • Hallandale Beach, Florida
    • +3 more
    Apr 2, 2020

    Parkinson Disease Trial in Prague, Bern (Dopaminergic OFF drug state, DBS OFF state, Dopaminergic ON drug state)

    Recruiting
    • Parkinson Disease
    • Dopaminergic OFF drug state
    • +3 more
    • Prague, Czechia
    • +1 more
    Feb 28, 2023

    Parkinson's Disease, Off Episodes of Parkinson Disease Trial in Italy, United States (APL-130277, Placebo, Moxifloxacin)

    Completed
    Has Results
    • Parkinson's Disease
    • Off Episodes of Parkinson Disease
    • Scottsdale, Arizona
    • +14 more
    Jul 16, 2020

    Parkinson Disease Trial in Worldwide (IPX203 140 mg, IPX203 210 mg, IPX203 280 mg)

    Completed
    • Parkinson Disease
    • IPX203 140 mg
    • +3 more
    • Phoenix, Arizona
    • +97 more
    Apr 5, 2022

    Parkinson's Disease Trial in United States (XP21279 and carbidopa (experimental), Sinemet (comparator), Placebo for XP21279 and

    Completed
    • Parkinson's Disease
    • XP21279 and carbidopa (experimental)
    • +3 more
    • Phoenix, Arizona
    • +11 more
    Feb 16, 2021

    Parkinson Disease Trial (Placebo, UCB0022)

    Not yet recruiting
    • Parkinson Disease
    • (no location specified)
    Sep 20, 2023

    Dyskinesia, Drug-Induced, Parkinson Disease Trial (Safinamide Methanesulfonate 150mg, Safinamide Methanesulfonate 100mg,

    Withdrawn
    • Dyskinesia, Drug-Induced
    • Parkinson Disease
    • Safinamide Methanesulfonate 150mg
    • +2 more
    • (no location specified)
    Jun 15, 2020

    Parkinson Disease Trial in Montpellier (Classical ring stimulation, Stimulation in directional mode)

    Not yet recruiting
    • Parkinson Disease
    • Classical ring stimulation
    • Stimulation in directional mode
    • Montpellier, France
      Centre Hospitalier Uniersitaire de Montpellier
    Nov 28, 2022

    Opicapone Treatment Initiation Open-Label Study

    Active, not recruiting
    • Parkinson Disease
    • Los Gatos, California
    • +5 more
    Apr 7, 2022